Article 2
United Kingdom
The date on which the three-year period referred to in Article 1 will commence shall be determined by the Management Board of the European Medicines Agency.
United Kingdom
The date on which the three-year period referred to in Article 1 will commence shall be determined by the Management Board of the European Medicines Agency.